Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 34.14% ...
PiperSandler initiated coverage of Viking Therapeutics (VKTX) with an Overweight rating and $74 price target The company has generated one of the more compelling weight loss profiles in Phase 2 ...